Expression of Genes Relating Hypertension and Efficacy of 4-7-8 Breathing Control on Reducing Blood Pressure
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-59
SponsorBurapha University
About this trial
This study consists of two sub-studies. Study 1 investigates gene expression related to the development of hypertension in Thailand, and Study 2 examines the effectiveness of the 4-7-8 breathing technique in reducing blood pressure in individuals with hypertension.
Eligibility criteria
Qualifiers
Group of individuals with hypertension
Male or female
Aged between 18-59 years
Of Thai ethnicity
Disqualifiers
Has heart disease, such as valvular stenosis or regurgitation, coronary artery disease, or heart failure
Has obesity, defined as having a body mass index (BMI) of 30 kg/m² or higher
Has a fever or is currently experiencing an infectious disease, such as COVID-19, the flu, or other infections
Group of individuals with normal blood pressure
Trial design
Treatments tested in this trial
- Study 2: deep breathing
- Study 2: 4-7-8 breathing
- Study 2: slow breathing with device
Treatment groups
200 Participants
are divided into 4 treatment groupsLocations
1Map coordinates are unavailable for these locations. Locations are shown below instead.
Faculty of Allied Health Sciences, Burapha UniversityRecruiting20131, MueangChonburi, Changwat Chon Buri
Thailand
ThailandSponsors and collaborators
Source ClinicalTrials.gov